Description |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Searle |
Aminophylline 120ml |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Sanofi |
Benzoyl Metronidazole 120ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Aqvida |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Macter Pharma
|
Zoledronic Acid 4mg/5ml
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Topotecan 4mg/4ml
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Content | Aminophylline is used to prevent and treat wheezing, shortness of breath, and difficulty breathing caused by asthma, chronic bronchitis. | "Metronidazole Benzoate is indicated for the treatment of infections caused by a wide range of anaerobic, protozoan and bacteroid bacteria, including trichomoniasis, amebiasis, vaginosis and gingivitis."
| Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Zoledronic acid is used to treat high levels of calcium in the blood that may be caused by certain types of cancer.
| Topotecan is an antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer.
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
|
Reviews
There are no reviews yet.